“GLP-1 Receptor Agonists and Substance Use Disorders: A Public Health Opportunity With Emerging Safety Concerns”. 2025. Epidemiology, Biostatistics, and Public Health 21 (1). https://doi.org/10.54103/2282-0930/29800.